BioLife Solutions (BLFS) Earnings Analysis

BioLife Solutions (BLFS) next reports earnings on 2026-08-06, consensus EPS -0.02 USD. Last quarter (2026-05-07) it beat with EPS 0.04 USD vs 0.01 USD est (+300%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E -144.21.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BLFS next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-0.02 USD
Revenue estimate0.03B

BLFS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-070.04 USD0.01 USD+300%Beat
2026-02-260.04 USD-0.02 USD+300%Beat
2025-11-060.04 USD0.002 USD+1900%Beat
2025-05-080.04 USD-0.04857 USD+182.4%Beat
2025-03-03-0.01 USD-0.06 USD+83.3%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

BLFS valuation and analyst view

Trailing P/E-144.21
Trailing EPS-0.2166 USD
Price / book4.06
Dividend yield0.00%
Market cap1.53B
Analyst consensusBuy (17 buy / 0 hold / 0 sell)
Avg price target31 USD

Related research pages

Frequently asked questions

When is BioLife Solutions (BLFS)'s next earnings date?

BioLife Solutions is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.02 USD and revenue estimate of 0.03B.

Did BLFS beat earnings last quarter?

In its 2026-05-07 report, BLFS posted EPS of 0.04 USD versus a 0.01 USD estimate — a beat of 300%.

What is BLFS's earnings track record?

Over the last 5 reported quarters with consensus data, BLFS beat estimates 5 times (100%).

What is BLFS's current P/E ratio and EPS?

BLFS trades at a trailing P/E of -144.21 on trailing EPS of -0.2165975464054465 USD.

What do analysts rate BLFS?

Analyst consensus is "Buy" across 17 ratings (0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 31 USD.